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mune response and contributes to autoimmune pathogenesis. Here, Notch signaling was found to be
activated in CD4þ T cells and synovial tissue from collagen-induced arthritis mice. In vivo adminis-
tration of the g-secretase inhibitor N-[N-(3,5-diﬂuorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl
ester (DAPT) substantially reduced the severity of arthritic symptoms and joint damage in collagen-
induced arthritis mice. Notably, DAPT treatment signiﬁcantly suppressed Th1- and Th17-cell re-
sponses in spleen and lymph nodes and reduced IFN-g and IL-17 levels in plasma. In polarization
culture, DAPT treatment markedly reduced Th17 cell expansion from naïve T cells, whereas fusion
protein of the Notch receptor ligand delta-like 3 signiﬁcantly increased the frequency and absolute
number of Th17 cells. These results suggest a novel therapeutic strategy for treatment of human
rheumatoid arthritis by targeting Notch signaling using g-secretase inhibitors. (Am J Pathol 2014, 184:
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Disclosures: None declared.Numerous studies have demonstrated that Notch signaling is
critically involved in the regulation of immune response. An
increasing body of evidence indicates that dysregulated
Notch activation contributes to autoimmune pathogenesis.
Notch signaling is initiated by ligand engagement of Notch
receptors. To date, four Notch receptors (Notch 1 to 4) and
ﬁve of their ligands (delta-like 1, 3, and 4 and Jagged-1
and -2) have been identiﬁed in mammals. Upon ligand
binding, the intracellular domain (ICD) of the receptor is
proteolytically cleaved by g-secretase and translocated into
the nucleus, where it associates with the RBP-Jk transcrip-
tion factor and regulates the expression of various target
genes, including members of the hairy enhancer of split
(Hes) or hairy related (Hey and Hrt) gene families. Although
Notch signaling is known to be critical primarily in tissue
and organ formation during embryonic development, accu-
mulating evidence also suggests that it plays an importantstigative Pathology.
.role in the pathogenesis of various disorders, including tu-
mors and autoimmune diseases.1e4
Rheumatoid arthritis (RA), a chronic inﬂammatory auto-
immune disease of the synovial joints, is characterized by
leukocyte inﬁltration and synoviocyte activation, leading to
destruction of cartilage and bone.5 Recent ﬁndings suggest
the potential role of Notch signaling in the pathogenesis of
RA. In one study, the expression pattern of Notch homologs
among synovium from RA patients differed from that of
healthy subjects.6 Our research group has previously char-
acterized the different expression proﬁles of Notch-related
Jiao et almolecules in peripheral T helper cells of RA patients and
healthy control subjects.7 Others have shown that g-secretase
inhibitors (GSIs) can effectively block the signaling from
Notch receptors by preventing the release of ICD and tran-
scriptional activation, which suggests the potential applica-
tion of a GSI as a novel therapeutic approach for diseases
with constitutive Notch activation.8,9 In addition, Notch
signaling has been shown to be essential for the differentia-
tion and function of various immune cells, including T cells,
B cells, dendritic cells, and macrophages, that are involved in
driving the chronicity and destructiveness of autoimmune
arthritis.10e13 Injection of a soluble Jagged1-encoding
plasmid before or even after initial collagen type II immu-
nization has been shown to suppress the disease severity in
collagen-induced arthritis (CIA) mice by providing a nega-
tive signal in CD8þ T cells without affecting CD4þ T cells.14
It has become clear that distinct Notch ligands have differ-
ential abilities in modulating T cell differentiation. Interest-
ingly, our previous in vitro experiments showed that
activation of Notch signaling with its ligand delta-like 1
promotes Th1/Th17 responses.15 Many studies, including
our recent work, have highlighted a critical role of Th17 cells
during the pathogenesis of RA and CIA in both human and
mouse.16 Upon interaction with synovial ﬁbroblasts, Th17
cells (but not Th1 cells) from patients with early RA are
potent inducers of matrix metalloproteinases and proin-
ﬂammatory cytokines, including autocrine IL-17A.17 In the
present study, we addressed the question of how the blockade
of Notch signaling in vivo affects Th1/Th17 cell responses
and the development of autoimmune arthritis.
We tested the effect of N-[N-(3,5-diﬂuorophenacetyl-L-
alanyl)]-S-phenylglycine t-butyl ester (DAPT), a GSI, on the
development of CIA in mice. We demonstrated the activa-
tion of Notch signaling in CD4þ T cells of CIA mice and
found that in vivo treatment with the GSI DAPT ameliorated
arthritis development via suppressing Th1 and Th17 re-
sponses. These results indicate that the targeting of Notch
signaling by GSIs may prove to be beneﬁcial for the treat-
ment of autoimmune arthritis.
Materials and Methods
Mice
Male DBA/1J mice (8 to 10 weeks of age) were supplied by
the Model Animal Research Center of Nanjing University
(Nanjing, China) and were maintained in a speciﬁc pathogene
free animal facility at Jiangsu University. All animal ex-
periments were conducted with approval of the Scientiﬁc
Investigation Board of Jiangsu University.
Induction of CIA
For CIA induction, DBA/1J mice were ﬁrst injected subcu-
taneously in the base of the tail with 100 mg of bovine
collagen type II (Chondrex, Redmond, WA) emulsiﬁed in1086Freund’s complete adjuvant (Sigma-Aldrich, St. Louis, MO),
followed 21 days later by a boost with 100 mg of the same
bovine collagen type II (Chondrex) emulsiﬁed in Freund’s
incomplete adjuvant (Sigma-Aldrich) via the same route, as
described previously.11,12 With the same protocol, but using
PBS in place of collagen type II, adjuvant-treated DBA/1J
mice served as controls. For assessing the severity of arthritis,
clinical symptoms were evaluated on a ﬁve-point scale: grade
0Z no swelling; grade 1Z paw with detectable swelling in
a single digit; grade 2Z paw with swelling in more than one
digit; grade 3 Z paw with swelling of all digits and instep;
and grade 4Z severe swelling of the paw and ankle.
Treatment of CIA Mice with DAPT
DAPT, an inhibitor of Notch signaling, was suspended in
dimethyl sulfoxide, and 1.0 mg/kg and 5.0 mg/kg DAPT (or
dimethyl sulfoxide alone as vehicle; 0 mg/kg DAPT) was
administered intraperitoneally on the day before the ﬁrst
immunization, followed by administration every other day
throughout the course of disease (n Z 5 mice per group).
On day 36, mice were sacriﬁced and ankle joints were
harvested and examined radiographically and histologically.
Cell suspensions of spleen and draining inguinal lymph
nodes (LNs) were prepared for frequency analysis of T cell
subsets by ﬂow cytometry and for CD4þ T-cell puriﬁcation
by magnetic bead separation. CD4þ T cells were puriﬁed by
depleting non-CD4þ T cells using a CD4þ T-cell isolation
kit (Miltenyi Biotec, Auburn, CA). Plasma samples were
also collected for measuring cytokine concentration.
Western Blot Analysis of Notch Intracellular Domain
For protein extraction, CD4þ T cells were lysed and denatured
by boiling in Laemmli sample buffer (62.5 mmol/L Tris-HCl,
glycerol, 10% SDS, 2-mercaptoethanol, 1% bromophenol
blue) for 10 minutes. Cells were then centrifuged in a cold
room (4C to 8C) at 12,000  g for 10 minutes. The super-
natant was used for Western blot (WB) analysis. Denatured
proteins (5 mg) were resolved by 10% SDSePAGE and
blotted onto a nitrocellulose membrane (Bio-Rad Labora-
tories, Hercules, CA), followed by overnight incubation at 4C
with antibody against cleaved Notch intracellular domain
(NICD) (Val 1744; Cell Signaling Technology, Danvers,
MA). After incubation with horseradish peroxidaseelabeled
secondary antibody, the labeled products were visualized
using a Pierce enhanced chemiluminescence detection system
(Thermo Fisher Scientiﬁc, Waltham, MA) and quantitated
using a chemiluminescence and ﬂuorescence imaging system
(Beijing Sage Creation Science, Beijing, China). Antieb-actin
(Sigma-Aldrich) was used as a loading control.
Histopathologic Analysis of Joint Tissue
Hind-paw ankle joints were ﬁxed in 10% phosphate-
buffered formalin for 72 hours, then decalciﬁed in 10%ajp.amjpathol.org - The American Journal of Pathology
Notch Signaling in CIAnitric acid for 48 hours before parafﬁn embedding. Tissue
sections (4 mm thick) were prepared for H&E staining.
IHC Staining of NICD
Parafﬁn sections of mouse ankle joint tissue were rehydrated
and treated with 15% hydrogen peroxide. Samples were
blocked with 10% rat serum and then were incubated with
primary antibody against cleaved NICD (Val 1744; Cell
Signaling Technology) and secondary antibody (horseradish
peroxidaseelabeled anti-rabbit IgG). Diaminobenzidine
(DAB) substrate was used for color reaction.
Radiological Examination
Radiography of mouse hindlimbs was performed using a
mammographic imager (GIOTTO; I.M.S., Bologna, Italy).
All images were obtained using exposure settings of 22 kVp
(peak voltage) and 6 mAs (exposure) and were evaluated by
two radiologists who were masked to the experimental
conditions.
Flow Cytometric Analysis
For analysis of Th1/Th2 and Th17 cells, cell suspensions
were stimulated for 5 hours using 50 ng/mL of phorbol
myristate acetate (Sigma-Aldrich) and 1 mg/mL ionomycin
(Sigma-Aldrich) in the presence of 5 mg/mL brefeldin A
(Sigma-Aldrich) at 37C and in a 5% CO2 atmosphere. Cells
were ﬁrst stained extracellularly with anti-CD4eﬂuorescein
isothiocyanate (eBioscience, San Diego, CA), then were
ﬁxed and permeabilized with IntraPrep permeabilization re-
agent (Beckman Coulter, Brea, CA), and ﬁnally were stained
intracellularly with antieIFN-gephycoerythrin, antieIL-4e
phycoerythrin, or antieIL-17Aephycoerythrin. For analysis
of regulatory T (Treg) cells, the cell suspensions were
surface-labeled with anti-CD4eﬂuorescein isothiocyanate
without phorbol myristate acetate and ionomycin stimula-
tion, followed by ﬁxation and permeabilization and intra-
cellular staining with anti-FoxP3ephycoerythrin. Labeled
cells were washed and analyzed with a FACSCalibur ﬂow
cytometer (BD Biosciences, San Jose, CA) using CellQuest
software version 3.2 (BD Biosciences). As control, each
staining was compared with the appropriately labeled isotype
control antibody.
Determination of Plasma Cytokines by Cytometric Bead
Array
The levels of plasma IFN-g, IL-4, IL-10, IL-17, and IL-22
were determined by cytometric bead array, using a mouse
Th1/Th2/Th17/Th22 13-plex FlowCytomix multiplex kit
(eBioscience, San Diego, CA), and were analyzed on a
FACSCalibur ﬂow cytometer (BD Biosciences, San Jose,
CA). Standard curves were determined for each cytokine
from a range of 27 to 20,000 pg/mL. The quantity (pg/mL)The American Journal of Pathology - ajp.amjpathol.orgof each respective cytokine was calculated using Flow-
Cytomix Pro 2.1 software.
Th17 Cell Expansion in Vitro
CD4þ T cells were puriﬁed from spleen of naïve mice using
magnetic activated cell sorting (Miltenyi Biotec); purity was
routinely >95%. Cells were cultured with plate-bound anti-
CD3 and anti-CD28 antibodies, TGF-b, IL-6, and TNF-a to
induce Th17 cell expansion in vitro. At the beginning of
culture, 10 mmol/L of DAPT or of the fusion proteins of
Notch ligands delta-like 1 (D1) and delta-like 3 (D3) was
added at the beginning of culture. Cells were harvested on
day 7 and were assayed for intracellular cytokines. Culture
supernatants were analyzed for cytokine concentrations by
cytometric bead array.
Statistical Analysis
Two-tailed Student’s t-test and analysis of variance test
were used for determining signiﬁcant differences between
groups. P < 0.05 was considered statistically signiﬁcant.
Results
Notch Signaling Is Increased in CD4þ T Cells and
Synovial Tissue from CIA Mice
To determine whether Notch signaling is activated in CD4þ
T cells from CIA mice, we examined and compared the
expression of NICD in CD4þ T cells from spleen and LNs
of CIA and control mice using WB to detect endogenous
levels of activated NICD only when released by cleavage
between Gly1743 and Val1744. NICD expression was
substantially up-regulated in CD4þ T cells of spleen and
LNs from CIA mice, compared with control mice (Figure 1,
A and B). In addition, up-regulation of NICD was detected
in the synovial tissue from CIA mice, relative to control
mice (Figure 1C). These results indicate increased activation
of Notch signaling in CD4þ T cells during development of
autoimmune arthritis.
Inhibition of Notch Signaling Ameliorates Arthritis
Development in CIA Mice
To determine whether inhibition of Notch signaling in vivo
can affect the development of autoimmune arthritis, we
administered DAPT, an inhibitor of Notch signaling, during
the induction of CIA. DAPT treatment signiﬁcantly reduced
the severity of arthritic symptoms in a dose-dependent
manner, as indicated by markedly decreased incidence of
disease development and clinical scores of arthritis in CIA
mice, compared with vehicle-treated CIA controls (Figure 2,
A and B). Notably, differences in disease severity scores
were statistically signiﬁcance at 7 days after the second
immunization. Moreover, radiological examination of the1087
Figure 1 Notch signaling is activated in CD4þ T cells and synovial
tissue of CIA mice. DBA/1J mice were ﬁrst immunized with bovine collagen
type II in Freund’s complete adjuvant and given booster injections in
Freund’s incomplete adjuvant on day 21 to induce CIA. Mice were sacriﬁced
on day 36. CD4þ T cells were puriﬁed from spleen and LNs of CIA mice and
normal control mice. NICD expressed by CD4þ T cells and synovial tissue
was determined by WB and IHC, respectively. A: Representative WB results
of three independent experiments. B: Quantitative analysis of NICD
expression in each group, normalized to b-actin. C: Representative IHC
results of NICD expression in synovium from CIA and control mice of three
independent experiments. Data are expressed as means  SD. n Z 5 mice
per group. *P < 0.05. Original magniﬁcation, 400.
Jiao et alankle joints 2 weeks after the second immunization revealed
that bone erosion was substantially reduced in the joints of
DAPT-treated CIA mice (Figure 2C). Histopathological
analysis of the joints treated with DAPT conﬁrmed greatly
reduced synovial hyperplasia, pannus formation, and carti-
lage destruction, compared with those in control groups
(Figure 2D). However, DAPT treatment after onset of CIA1088did not affect the clinical score in this model (Supplemental
Figure S1).
Inhibition of Notch Signaling Suppresses Th1/Th17
Responses in CIA Mice
Because helper T cells are known to play a potent proin-
ﬂammatory role in autoimmune arthritis, we next evaluated
the potential effect of Notch inhibition on the generation of
T-cell subsets in CIA mice. We ﬁrst compared the NICD
levels in puriﬁed CD4þ T cells from CIA mice with or
without DAPT treatment and found that DAPT treatment
decreased NICD levels in CD4þ T cells from spleen and
LNs of CIA mice (Figure 3, A and B). Next, we determined
the populations of Th1/Th2, Treg, and Th17 cells in both
spleen and LNs from CIA mice, with and without DAPT
treatment. As expected, Th1 and Th17 cell populations were
greatly increased in both spleen and LNs from CIA mice,
compared with normal controls, whereas DAPT treatment
signiﬁcantly decreased the frequency of Th1 and Th17 cells
in both spleen and LNs in CIA mice (Figure 3, C and D and
Figure 4, A and B). No obvious difference in the frequency
of Th2 cells was observed among the three groups. Collagen
type II immunization increased the Treg population in both
spleen and LNs in CIA mice; however, this was not down-
regulated by DAPT treatment. Consistent with the reduced
frequency of Th1 and Th17 cells, the absolute number of
both T-cell subsets was also markedly decreased in both
spleen and LNs from CIA mice with DAPT inhibition of
Notch (Figure 5, A and B). Taken together, these ﬁndings
indicate that blocking of Notch signaling in vivo suppresses
the generation of Th1 and Th17 cell in CIA mice.
Inhibition of Notch Signaling Reduces Levels of IFN-g
and IL-17 in the Peripheral Blood of CIA Mice
To further examine effect of Notch inhibition on cytokine
production, we examined cytokine expression in the pe-
ripheral blood of CIA mice by cytometric bead array. Levels
of plasma IFN-g and IL-17 were increased in CIA mice
treated with vehicle alone, compared with normal mice
(P < 0.05) (Figure 5C). However, levels of plasma IFN-g
and IL-17 were signiﬁcantly decreased in DAPT-treated CIA
mice (P < 0.05). No signiﬁcant change in IL-4, IL-10, or IL-
22 levels was observed among the three groups (P > 0.05).
Notch Signaling Regulates Th17 Cell Differentiation
in Vitro
To conﬁrm the involvement of Notch signaling in Th17 cell
differentiation, we established in vitro culture for murine
Th17 cell expansion, using a combination of cytokines
(TGF-b, IL-1b, and IL-6) in the presence or absence of the
GSI DAPT. Treatment of naïve T cells with DAPT mark-
edly reduced the frequency of Th17 cells in polarized Th17
differentiation condition (Figure 6A). Both the total numberajp.amjpathol.org - The American Journal of Pathology
Figure 2 Blockade of Notch signaling by the
GSI DAPT ameliorates disease in CIA mice. DBA/1J
mice were immunized by collagen type II to induce
arthritis. The mice were administered DAPT [1.0
(open squares) or 5.0 mg/kg (white circles) i.p.] or
vehicle (black squares) on the day before primary
immunization, followed by administration every
other day. A: The incidence of arthritis develop-
ment in mice with or without DAPT. B: Evaluation
of the severity of arthritis in terms of clinical
arthritis score. C and D: On day 36, ankle joints
were prepared for radiological examination (C) and
for histopathological examination by H&E staining
(D). Data are expressed as means  SD. n Z 10
(A) or 5 (B) mice per group. *P < 0.05 versus
vehicle-treated CIA mice. Original magniﬁcation,
100.
Notch Signaling in CIAof Th17 cells and the level of IL-17 in supernatant were also
signiﬁcantly decreased in DAPT-treated T-cell cultures
(Figure 6, B and C). These data indicate the involvement of
Notch signaling in Th17 cell differentiation in vitro.The American Journal of Pathology - ajp.amjpathol.orgWe then investigated whether the fusion proteins of
Notch ligands can enhance the differentiation of Th17 cells.
Splenic CD4þ T cells from normal mice were puriﬁed and
cultured for 7 days under a polarized Th17 differentiationFigure 3 DAPT treatment decreases the fre-
quency of Th1 and Th17 cells in spleen of CIA mice.
The mice were administered DAPT (5.0 mg/kg i.p.)
or vehicle on the day before primary immunization,
followed by administration every other day. CD4þ T
cells were puriﬁed from spleen and inguinal LNs
from CIA mice treated with DAPT (CIAþD) or with
vehicle (CIA). A: NICD expressed by CD4þ T cells
was determined by WB. B: Quantitative analysis of
NICD expression in each group, normalized to
b-actin. C: The frequency of Th1/Th2, Treg, and
Th17 cells in spleen was determined by ﬂow
cytometry. D: Representative ﬂow cytometry data
for T-cell subsets gated on CD4þ T cells in spleen.
Data are expressed as means  SD from three in-
dependent experiments. n Z 5 mice per group.
*P < 0.05. FITC, ﬂuorescein isothiocyanate.
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Figure 4 DAPT treatment decreases the fre-
quency of Th1 and Th17 cells in LNs of CIA mice.
The mice were administered DAPT (5.0 mg/kg i.p.)
or vehicle on the day before primary immunization,
followed by administration every other day. A: The
frequency of Th1/Th2, Treg, and Th17 cells in LNs
was determined by ﬂow cytometry. B: Represen-
tative ﬂow cytometry data for T-cell subsets gated
on CD4þ T cells in LNs. Data are expressed as
means  SD from three independent experiments.
n Z 5 mice per group. *P < 0.05.
Jiao et alcondition in the presence of the fusion proteins of Notch
ligands D1 and D3. Both the frequency of Th17 cells and
their absolute number were signiﬁcantly increased on
addition of D3, consistent with elevated level of IL-17 in
supernatant; however, D1 treatment did not show any
obvious effect on Th17 cell expansion (Figure 6, DeF).
These results further suggest that Notch signaling mediated
by different ligands may play differential roles in the dif-
ferentiation of Th17 cells.A
C
B
Figure 5 DAPT treatment decreases the number of Th1 and Th17 cells in s
administered DAPT (5.0 mg/kg i.p.) or vehicle on the day before primary immuni
number of Th1 cells (A) and Th17 cells (B) in spleen and LNs was recorded. C: Pla
expressed as means  SD from three independent experiments. n Z 5 mice per
1090Discussion
In the present study, we detected enhanced activation of
Notch signaling in CD4þ T cells from both spleen and LNs,
as well as in synovial tissue of CIA mice, consistent with
our previous ﬁndings that peripheral T helper cells from RA
patients exhibit signiﬁcantly altered expression proﬁles of
Notch receptors and enhanced activation of Notch signaling,
compared with healthy controls.7 Given that dysfunction ofpleen and LNs, as well as plasma cytokines, of CIA mice. The mice were
zation, followed by administration every other day. A and B: The absolute
sma levels of cytokines were determined by cytometric bead array. Data are
group. *P < 0.05.
ajp.amjpathol.org - The American Journal of Pathology
Figure 6 Notch signaling regulates Th17 cell expansion in vitro. Th17 cells were expanded from mouse CD4þ T cells in vitro in the presence of several
cytokines (TGF-b, IL-1b, and IL-6) and simultaneously treated with GSI, DAPT (AeC) or the fusion proteins of Notch ligands D1 and D3 (DeF). The frequency
of Th17 cells was determined by ﬂow cytometry (A and D), the absolute number of Th17 cells was enumerated (B and E), and IL-17 levels in culture su-
pernatant were determined by cytometric bead array (C and F). Data are expressed as means  SD from three independent experiments. nZ 5 mice per group.
*P < 0.05. Cks, cytokines.
Notch Signaling in CIACD4þ T cells has been implicated in the development of
RA, these results suggest that inhibition of Notch signaling
might suppress the disease course of RA.
The effect of Notch signaling inhibition by GSI on the
course of several autoimmune inﬂammatory disorders has
been addressed in several studies. Kavian et al18 reported the
activation of Notch signaling in skin, lung, and splenocytes
from a mouse model of systemic sclerosis and in the skin of
patients with systemic sclerosis. In mice with experimental
systemic sclerosis, inhibition of Notch signaling by the GSI
DAPT limited both ﬁbrosis and autoimmune activation.
Blockade of Notch signaling using a GSI effectively abro-
gated Th1 polarization and altered disease progression of
experimental autoimmune encephalomyelitis, an animal
model of multiple sclerosis.10,19 In models of autoimmune
lymphoproliferative syndrome and systemic lupus erythe-
matosus, inhibition of Notch signaling with the GSI DAPT
can profoundly and safely decrease all disease parameters.20
In the present study, we used the GSI DAPT to block
Notch signaling in a CIA mouse model and demonstrated
that in vivo administration of DAPT effectively reduces
disease severity and joint damage. Taken together, these
ﬁndings demonstrate the effectiveness and safety of DAPT
in animal models and strongly suggest that inhibition of
Notch signaling could be an effective strategy for the
treatment of autoimmune diseases. GSIs have been actively
tested in clinical trials for Alzheimer disease for their po-
tential in blocking the generation of Ab peptide,21,22 and
further experiments are needed to identify other mechanismsThe American Journal of Pathology - ajp.amjpathol.orgof DAPT action in vivo. Given that DAPT treatment after
onset did not affect the clinical score in our CIA model, the
best time window for DAPT therapy of CIA (eg, day 7, day
14, or day 21) needs to be further examined.
To elucidate the possible mechanism underlying the
therapeutic effect of DAPT in targeting autoimmune arthritis
in this CIA model, we analyzed the changes of Th1/Th2,
Treg, and Th17 cells in both spleen and LNs of CIA mice on
DAPT treatment. Th17 cells are a well-recognized proin-
ﬂammatory helper T-cell subset in the development of CIA,
and Th17 cells play a similar role in human RA pathogen-
esis. Th17 cells that secrete the cytokines IL-17A and IL-
17F and express the lineage-speciﬁc transcription factor
RORC (RORgt in mice) represent a distinct lineage of
CD4þ T cells. In addition to their role in RA, Th17 cells and
their effector molecules are also associated with the patho-
genesis of several autoimmune and inﬂammatory diseases,
including systemic lupus erythematosus, multiple sclerosis,
psoriasis, inﬂammatory bowel disease (IBD), allergy, and
asthma.23 In the present study, DAPT treatment decreased
the level of NICD in CD4þ T cells from spleen and LNs of
CIA mice, which suggests effective suppression of Notch
signaling in CD4þ T cells in vivo. Furthermore, Notch in-
hibition by DAPT reduced the frequency and total number
of Th1 and Th17 cells in spleen and LNs, together with
plasma levels of IFN-g and IL-17, in CIA mice. In a recent
study, GSI blocking of Notch signaling ameliorated the
severity of experimental autoimmune encephalomyelitise
induced inﬂammation and Th17 differentiation in vivo.101091
Jiao et alNotch signaling is also critical in the differentiation not only
of Th1 and Th17 cells, but also of Treg cells.24,25 Interest-
ingly, we did not observe any signiﬁcant changes in Treg
cells in spleen and LNs in CIA mice with DAPT treatment.
Thus, these ﬁndings indicate that suppression of experi-
mental arthritis by blocking of Notch signaling is due in part
to the inhibition of Th1 and Th17 cell differentiation.
Although the role of Notch signaling in the pathogenesis of
RA is yet to be fully elucidated, we have recently reported
that inhibition of Notch signaling by DAPT or Notch 3
antibody decreases collagen-speciﬁc T-cell proliferation and
attenuates Th1- and Th17-type responses, whereas treatment
with Notch ligand D1 promotes Th1/Th17 responses.15
In vitro, GSIs extinguish expression of Notch, IFN-g, and
Tbx21 in Th1-polarized CD4þ cells, whereas ectopic
expression of activated Notch1 restores Tbx21 transcription.
In vivo, administration of GSIs substantially impedes Th1-
mediated disease progression in a mouse experimental
autoimmune encephalomyelitis model of multiple scle-
rosis.26 In the present study, we assessed the effect of Notch
signaling on Th17 polarization in vitro, using several cyto-
kines other than antigen-speciﬁc stimulation. Treatment with
DAPT markedly reduced the frequency and total number of
Th17 cells, as well as IL-17 production in polarized Th17
differentiation condition. These results are in accord with
ﬁndings of a previous study, in which IL-CHO and com-
pound E (two chemically distinct GSIs) were used to inhibit
g-secretase.10 Our present ﬁndings also provide further evi-
dence that Notch signaling plays an important role in the
Th17 differentiation, because addition of the Notch ligandD3
signiﬁcantly increased the frequency and total number of
Th17 cells, as well as the supernatant level of IL-17 in Th17
polarization condition. Taken together, the present results
identify the Notch signaling pathway as a potential thera-
peutic target in the treatment of autoimmune arthritis.
Conclusion
With the present study, we have demonstrated that Notch
signaling is activated in CD4þ T cells during the develop-
ment of autoimmune arthritis and that inhibition of Notch
signaling by DAPT, a GSI, suppresses the disease severity
of CIA in mice. Our results also reveal that Notch signaling
plays an important role in Th1 and Th17 cell differentiation.
These ﬁndings support a role of Notch signaling in the
development of experimental arthritis, which may facilitate
the validation of targeting Notch signaling using GSIs as a
novel therapeutic strategy for the treatment of human RA.
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